{
  "id": 1849186,
  "title": "Pacific Biosciences CEO Mark van Oene sells $30,409 in stock",
  "url": "https://urgent.news/2026/08/19/pacific-biosciences-ceo-mark-van-oene-sells-30-409-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-19T02:15:56.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/pacific-biosciences-ceo-mark-van-oene-sells-30409-in-stock-93CH-4866368"
  },
  "original_language": "en",
  "account": "Pacific Biosciences of California CEO Mark van Oene sold 26,911 shares of the company's stock on August 17, 2026. The sale amounted to $30,409, with shares exchanged at a weighted average price of $1.13, falling between $1.13 and $1.15 per share. The transaction occurred as PACB stock hovers around its 52-week low of $1.07, marking a 39% decrease year-to-date. Currently, the stock is trading at $1.14, a substantial drop from its 52-week high of $2.73. This sale was necessary to satisfy tax withholding requirements related to the vesting of restricted stock units. As a result of this transaction, Mr. Van Oene now owns 2,705,853 shares of Pacific Biosciences common stock.\n\nInvestors looking for additional insights into PACB may find value in InvestingPro's 7 exclusive tips and comprehensive Pro Research Reports on this stock and 1,400+ other US equities. Separately, PacBio's latest earnings report for Q2 2026 showed revenue of $39.0 million and an adjusted loss of $0.14 per share, both falling short of Wall Street's expectations. The company also adjusted its full-year guidance, stating that achieving cash flow breakeven will be delayed beyond initial projections. Despite these setbacks, PacBio's revenue remained largely unchanged compared to the prior year.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Meiragtx CEO Forbes sells $859,320 in company stock",
        "url": "https://urgent.news/2026/08/19/meiragtx-ceo-forbes-sells-859-320-in-company-stock",
        "published": "2026-08-19T02:31:03.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}